Publication:
Targeting gut microbiome, is it always a therapeutic option?

dc.contributor.authorRodríguez-Nogales, Alba
dc.contributor.authorGálvez, Julio
dc.date.accessioned2023-02-09T09:47:10Z
dc.date.available2023-02-09T09:47:10Z
dc.date.issued2020-11-09
dc.description.abstractObstructive sleep apnea (OSA) is a common respiratory disorder associated with cardiovascular comorbidities and cancer due to chronic intermittent hypoxia (CIH). This condition affects the gut microbiome, altering its diversity and increasing intestinal permeability, which contributes to insulin resistance. Dysbiosis is linked to chronic diseases such as metabolic syndrome and cardiovascular disorders.
dc.description.versionSi
dc.identifier.citationRodríguez-Nogales A, Gálvez J. Targeting gut microbiome, is it always a therapeutic option? EBioMedicine. 2020 Dec;62:103099. doi: 10.1016/j.ebiom.2020.103099.
dc.identifier.doi10.1016/j.ebiom.2020.103099
dc.identifier.essn2352-3964
dc.identifier.issn2352-3964
dc.identifier.pmcPMC7656137
dc.identifier.pmid33161230
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656137/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.ebiom.2020.103099
dc.identifier.urihttp://hdl.handle.net/10668/16566
dc.journal.titleEBioMedicine
dc.journal.titleabbreviationEBioMedicine
dc.language.isoen
dc.organizationHospital Universitario Virgen de las Nieves
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number103099
dc.provenanceCuración de contenido realizada 09/09/2024
dc.publisherThe Lancet Publishing Group
dc.pubmedtypeLetter
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectObstructive sleep apnea (OSA)
dc.subjectChronic intermittent hypoxia (CIH)
dc.subjectGut microbiome
dc.subjectOxidative stress
dc.subjectInsulin resistance
dc.subject.decsApnea obstructiva del sueño (AOS)
dc.subject.decsHipoxia intermitente crónica (HIC)
dc.subject.decsDisbiosis del microbioma intestinal
dc.subject.decsSistema nervioso simpático
dc.subject.decsEnfermedades cardiovasculares y comorbilidades
dc.subject.meshAnimals
dc.subject.meshDisease Management
dc.subject.meshDisease Susceptibility
dc.subject.meshGastrointestinal Microbiome
dc.subject.meshHumans
dc.subject.meshPrecision Medicine
dc.titleTargeting gut microbiome, is it always a therapeutic option?
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number62
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC7656137.pdf
Size:
285.11 KB
Format:
Adobe Portable Document Format